Hochmair MJ, Vermaelen K, Mountzios G, Carcereny E, et al. Sotorasib (960 mg or 240 mg) once daily in patients with previously treated KRAS G12C-mutated advanced NSCLC. Eur J Cancer 2024;208:114204.
PMID: 39029295